Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D J Pearson

Showing results (51-60 of 195) with videos related to

Pageof 20
Sort By:
Leukemia|April 9, 2013
Novel therapies for children with acute myeloid leukaemiaA S Moore, P R Kearns, S Knapper, et al.
European Journal of Cancer (Oxford, England : 1990)|October 24, 2009
Persistent nephrotoxicity during 10-year follow-up after cisplatin or carboplatin treatment in childhood: relevance of age and dose as risk factorsRoderick Skinner, Annie Parry, Lisa Price, et al.
Cell Death and Differentiation|December 13, 2005
Overexpression of RARgamma increases death of SH-SY5Y neuroblastoma cells in response to retinoic acid but not fenretinideB B Goranov, Q D Campbell Hewson, A D J Pearson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2004
Cyclophosphamide metabolism in children with non-Hodgkin's lymphomaS Murray Yule, Lisa Price, Alex D McMahon, et al.
Environmental Research|August 1, 1979
Antibody-independent complement activation by cardroom cotton dustS A Kutz, S A Olenchock, J A Elliott, et al.
Pediatric Blood & Cancer|December 2, 2022
Systematic review of clinical drug development activities for neuroblastoma from 2011 to 2020Jaclynne H Nader, Florence Bourgeois, Rochelle Bagatell, et al.
Biochemical Pharmacology|February 14, 2002
Influence of isomerisation on the growth inhibitory effects and cellular activity of 13-cis and all-trans retinoic acid in neuroblastoma cellsGareth J Veal, Julie Errington, Christopher P F Redfern, et al.
The Lancet. Oncology|March 1, 2008
High-dose rapid and standard induction chemotherapy for patients aged over 1 year with stage 4 neuroblastoma: a randomised trialAndrew D J Pearson, C Ross Pinkerton, Ian J Lewis, et al.
Leukemia Research|June 14, 2011
Adaptation of the plasma inhibitory activity assay to detect Aurora, ABL and FLT3 kinase inhibition by AT9283 in pediatric leukemiaJennifer E Podesta, Richard Sugar, Matt Squires, et al.
Molecular Pharmacology|December 4, 2003
Growth and DNA damage-inducible transcription factor 153 mediates apoptosis in response to fenretinide but not synergy between fenretinide and chemotherapeutic drugs in neuroblastomaMarco Corazzari, Penny E Lovat, Serafina Oliverio, et al.
Pageof 20

Showing results (51-60 of 195) with videos related to

Sort By:
Pageof 20
Leukemia|April 9, 2013
Novel therapies for children with acute myeloid leukaemiaA S Moore, P R Kearns, S Knapper, et al.
European Journal of Cancer (Oxford, England : 1990)|October 24, 2009
Persistent nephrotoxicity during 10-year follow-up after cisplatin or carboplatin treatment in childhood: relevance of age and dose as risk factorsRoderick Skinner, Annie Parry, Lisa Price, et al.
Cell Death and Differentiation|December 13, 2005
Overexpression of RARgamma increases death of SH-SY5Y neuroblastoma cells in response to retinoic acid but not fenretinideB B Goranov, Q D Campbell Hewson, A D J Pearson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2004
Cyclophosphamide metabolism in children with non-Hodgkin's lymphomaS Murray Yule, Lisa Price, Alex D McMahon, et al.
Environmental Research|August 1, 1979
Antibody-independent complement activation by cardroom cotton dustS A Kutz, S A Olenchock, J A Elliott, et al.
Pediatric Blood & Cancer|December 2, 2022
Systematic review of clinical drug development activities for neuroblastoma from 2011 to 2020Jaclynne H Nader, Florence Bourgeois, Rochelle Bagatell, et al.
Biochemical Pharmacology|February 14, 2002
Influence of isomerisation on the growth inhibitory effects and cellular activity of 13-cis and all-trans retinoic acid in neuroblastoma cellsGareth J Veal, Julie Errington, Christopher P F Redfern, et al.
The Lancet. Oncology|March 1, 2008
High-dose rapid and standard induction chemotherapy for patients aged over 1 year with stage 4 neuroblastoma: a randomised trialAndrew D J Pearson, C Ross Pinkerton, Ian J Lewis, et al.
Leukemia Research|June 14, 2011
Adaptation of the plasma inhibitory activity assay to detect Aurora, ABL and FLT3 kinase inhibition by AT9283 in pediatric leukemiaJennifer E Podesta, Richard Sugar, Matt Squires, et al.
Molecular Pharmacology|December 4, 2003
Growth and DNA damage-inducible transcription factor 153 mediates apoptosis in response to fenretinide but not synergy between fenretinide and chemotherapeutic drugs in neuroblastomaMarco Corazzari, Penny E Lovat, Serafina Oliverio, et al.
Pageof 20